Brief: Olink Forms Agreement With Regeneron To Scale Proteomics Efforts
Feb 28 (Reuters) - Olink Holding AB (publ) OLK.O :
* ESTABLISHES AGREEMENT WITH REGENERON GENETICS CENTER TO
SCALE
THEIR PROTEOMICS EFFORTS, POTENTIALLY ENABLING A NEW ERA OF DRUG
DISCOVERY
Source text for Eikon: ID:nGNE8Nk1PD
Further company coverage: OLK.O
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Olink Holding AB (publ)
See all newsBrief: Olink Announces Receipt Of CMA Clearance For Proposed Acquisition By Thermo Fisher
UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal
Competition and Mkts - Merger Update : Thermo Fisher / Olink
Olink Holding AB (publ) reports results for the quarter ended in March - Earnings Summary
UK's CMA kicks off probe into Thermo Fisher-Olink deal